Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
about
Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@en
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@nl
type
label
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@en
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@nl
prefLabel
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@en
Chemo-immunotherapy (Gemcitabi ...... tinum-resistant Ovarian Cancer
@nl
P3098
NCT01639885